Cytokinetics Stock Skyrockets on Positive Results from Study

Cytokinetics Inc. reported positive results Wednesday from a key Phase 3 study of its experimental drug to treat heart disease.

Related Keywords

Fady Malik , Karuna Therapeutics Inc , Bristol Myers Squibb , Drug Administration , Rayzebio Inc , Bristol Myers Squibb Co , Myers Squibb , Karuna Therapeutics ,